HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.
5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Cardiovascular Engineering and Technology
Cardiovascular Engineering and Technology
Cardiovascular engineering is an area of computation medical technology that focuses on the study of cardiovascular illnesses and disorders, including basic science and experimental to clinical applications, and spans the range from the molecular to the whole body
Cardiovascular Technology: It refers to the technologies that are used to help and diagnose conditions associated with cardiovascular disease and diseases. These technologies are also utilized to help physicians diagnose and treat cardiac (heart) and peripheral vascular disorders (blood vessel), as well as during open-heart surgeries and pacemaker insertion surgeries.
Committee Members
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States Heart Congress 2027 Speakers
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain